Q1 2025 · 13F-HR
Knoll Capital Management, LLCholdings as filed
Filed 2025-05-15 · accession 0001104659-25-049384
$153.7M
Reported value
36
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 01438T106 | ALDX | Aldeyra Therapeutics Inc | $31.5M | 20.5% | 5,475,516 | Common | SOLE |
| G11196105 | — | Biohaven Pharmactl Hldg Co L | $20.0M | 13.0% | 830,879 | Common | SOLE |
| M40527109 | ENTX | Entera Bio Ltd | $10.0M | 6.50% | 5,881,879 | Common | SOLE |
| 78463V107 | GLD | SPDR Gold Trust | $9.2M | 6.00% | 32,000 | Common | SOLE |
| G59665102 | MGTX | MeiraGTX Holdings | $8.5M | 5.51% | 1,250,000 | Common | SOLE |
| 008474108 | AEM | Agnico Eagle Mines Ltd | $6.0M | 3.91% | 55,500 | Common | SOLE |
| 02155H200 | ALT | Altimmune Inc | $5.6M | 3.65% | 1,121,524 | Common | SOLE |
| 496902404 | KGC | Kinross Gold Corp | $5.5M | 3.61% | 440,000 | Common | SOLE |
| 80013R206 | AYS1 | Sandstorm Gold Ltd | $5.3M | 3.44% | 700,000 | Common | SOLE |
| 05337M104 | — | Avadel Pharmaceuticals Plc | $4.7M | 3.06% | 600,000 | Common | SOLE |
| 67576A100 | OCUL | Ocular Therapeutix Inc. | $4.4M | 2.86% | 600,400 | Common | SOLE |
| 351858105 | FNV | Franco Nev Corp | $3.9M | 2.56% | 25,000 | Common | SOLE |
| 28657F103 | ELTX | Elicio Therapeutics Inc | $3.9M | 2.53% | 630,915 | Common | SOLE |
| 03828A101 | APLT | Applied Therapeutics Inc | $3.8M | 2.48% | 7,799,687 | Common | SOLE |
| 29446Y502 | EQX | Equinox Gold Corp | $3.8M | 2.47% | 550,811 | Common | SOLE |
| 811916105 | SA | SEABRIDGE GOLD INC | $3.7M | 2.41% | 317,003 | Common | SOLE |
| 83056P715 | SKE | SKEENA RES LTD CAD | $3.2M | 2.07% | 315,400 | Common | SOLE |
| 55903Q104 | MQ8 | Mag Silver Corp | $2.6M | 1.69% | 170,000 | Common | SOLE |
| 46428Q109 | SLV | iShares Silver Trust | $2.5M | 1.61% | 80,000 | Common | SOLE |
| 67080N101 | NUVB | Nuvation Bio Inc | $1.8M | 1.17% | 1,025,000 | Common | SOLE |
| 92826C839 | V | Visa | $1.7M | 1.11% | 4,850 | Common | SOLE |
| 718172109 | PM | Philip Morris Intl. Inc | $1.6M | 1.03% | 10,000 | Common | SOLE |
| 099502106 | BAH | Booz Allen Hamilton HLDG COR | $1.4M | 0.88% | 13,000 | Common | SOLE |
| 780287108 | RGLD | Royal Gold Inc. | $1.2M | 0.80% | 7,550 | Common | SOLE |
| 464288760 | ITA | iSHares US Aerospace & Defense | $1.2M | 0.76% | 7,650 | Common | SOLE |
| 666807102 | NOC | Northrop Grumman Corp | $1.1M | 0.72% | 2,165 | Common | SOLE |
| 011532108 | AGI | Alamos Gold Inc | $1.1M | 0.71% | 41,000 | Common | SOLE |
| 962879102 | WPM | Wheaton Precious Metals Corp | $970,375 | 0.63% | 12,500 | Common | SOLE |
| 25243Q205 | DEO | Diageo PLC | $707,332 | 0.46% | 6,750 | Common | SOLE |
| 589492107 | MREO | Mereo Biopharma Group | $586,058 | 0.38% | 260,470 | Common | SOLE |
| 192108504 | CDE | Coeur Mining Inc | $569,101 | 0.37% | 96,132 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA | $538,515 | 0.35% | 498,625 | Common | SOLE |
| 64782A107 | NEWP | New Pac Metals Corp | $535,925 | 0.35% | 485,000 | Common | SOLE |
| 925050106 | VRNA | Verona Pharma | $447,541 | 0.29% | 7,049 | Common | SOLE |
| 68619K105 | — | Orgenesis, Inc. | $124,026 | 0.08% | 50,623 | Common | SOLE |
| 14161Y200 | CRDL | Cardiol Therapeutics Inc | $96,900 | 0.06% | 100,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.